IP Library Granted Patent US 12,423,808
Granted Patent B2
US 12,423,808 · App. 18/060,688 · Granted Sep 23, 2025

System and method for comparing SPECT and PET image data in theranostics

Inventors: Jonathan Sachs (Haifa, IL); Raz Carmi (Haifa, IL)
Assignee: GE PRECISION HEALTHCARE LLC
G06T7/0012G01T1/02G06T5/50G06V10/761G06T2207/10104G06T2207/10108G06T2207/20221
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,423,808
App. No.
18/060,688
Granted
Sep 23, 2025
Kind
B2
Abstract

A computing system includes computer readable medium and a processor. The computer readable medium includes a computer readable medium including a positron emission tomography (PET)-to-single photon emission tomography (SPECT) module with instructions for generating simulated SPECT image data based on first PET image data. The PET image data is acquired prior to a treatment course of a treatment regimen with a SPECT-based treatment/imaging radiopharmaceutical. The processor is configured to obtain the first PET image data, system parameters of a SPECT-CT imaging system utilized to generate corresponding SPECT image data for the treatment regimen and scan parameters utilized by the SPECT-CT imaging system to acquire the corresponding SPECT image data. The processor is further configured to execute the instructions to generate the simulated SPECT image data based on the PET image data and the system parameters and the scan parameters.

Claims (88)

1. A computing system, comprising:

computer readable medium including a positron emission tomography (PET)-to-single photon emission tomography (SPECT) module with instructions for generating simulated SPECT image data based on first PET image data, wherein the first PET image data is acquired prior to a treatment course of a treatment regimen with a SPECT-based treatment/imaging radiopharmaceutical; and

a processor configured to obtain the first PET image data, system parameters of a SPECT-CT imaging system utilized to generate corresponding SPECT image data for the treatment regimen and scan parameters utilized by the SPECT-CT imaging system to acquire the corresponding SPECT image data, and execute the instructions to forward project the PET image data into SPECT projections based on the system parameters and the scan parameters and reconstruct the SPECT projections to generate the simulated SPECT data.

2. The computing system of claim 1 , wherein the processor is further configured to:

normalize the SPECT projections to generate normalized SPECT projections;

add noise to the normalized SPECT projections to generate normalized SPECT projections with noise; and

reconstruct the normalized SPECT projections with noise to generate the simulated SPECT image data.

3. The computing system of claim 2 , wherein the processor is further configured to:

extract a second SPECT FOV from the PET image data;

forward project the PET image into second SPECT projections;

normalize the second SPECT projections to generate second normalized SPECT projections;

add noise to the second normalized SPECT projections to generate second normalized SPECT projections with noise;

reconstruct the second normalized SPECT projections with noise to generate second simulated SPECT image data; and

combine the simulated SPECT image data and the second simulated SPECT image data to create a single set of simulated SPECT image data.

4. The computing system of claim 1 , wherein the processor is further configured to:

obtain first SPECT image data acquired after the treatment course of the treatment regimen; and

compare the simulated SPECT image data and the first SPECT image data.

5. The computing system of claim 4 , wherein the processor is further configured to:

obtain second SPECT image data acquired after a second treatment course of the treatment regimen; and

compare at least one of the simulated SPECT image data or the first SPECT image data with the second SPECT image data.

6. The computing system of claim 1 , wherein the processor is further configured to:

obtain second PET image data acquired after the treatment regimen;

generate second simulated SPECT image data based on the second PET image data and the system and scan parameters; and

compare the simulated SPECT image data and the second simulated SPECT image data.

7. The computing system of claim 1 , wherein the processor is further configured to:

obtain second PET image data acquired after the treatment regimen; and

compare the PET image data and the second PET image data.

8. The computing system of claim 1 , wherein the processor is further configured to:

obtain second PET image data acquired after the treatment regimen;

generate second simulated SPECT image data based on the second PET image data and the system and scan parameters; and

compare the simulated SPECT image data and the second simulated SPECT image data.

9. The computing system of claim 1 , wherein the processor is further configured to:

obtain a dosimetry value of primary tissue of interest or healthy tissue in SPECT image data acquired after the treatment course of the treatment regimen;

identify the primary tissue of interest and secondary tissue of interest in the PET image data;

determine a value of a secondary-to-primary tissue of interest characteristic;

obtain a total radiation dose; and

estimate a radiation dose of the secondary tissue of interest based on the dosimetry value, the value of the secondary-to-primary tissue of interest characteristic and the total radiation dose.

10. The computing system of claim 9 , wherein the processor further estimates the radiation dose based on a factor indicative of an imaging relationship between SPECT and PET imaging.

11. A computer-implemented method, comprising:

obtaining first PET image data that was acquired prior to a treatment course of a treatment regimen with a SPECT-based treatment/imaging radiopharmaceutical;

obtaining system parameters of a SPECT-CT imaging system utilized to acquire SPECT image data for the treatment regimen and scan parameters utilized by the SPECT-CT imaging system to acquire the SPECT image data; and

generating a simulated SPECT image data by forward projecting the PET image data into SPECT projections based on the system parameters and the scan parameters and reconstructing the SPECT projections.

12. The computer-implemented method of claim 11 , further comprising:

normalizing the SPECT projections to generate normalized SPECT projections;

adding noise to the normalized SPECT projections to generate normalized SPECT projections with noise; and

reconstructing the normalized SPECT projections with noise to generate the simulated SPECT image data.

13. The computer-implemented method of claim 11 , further comprising:

extracting a second SPECT FOV from the PET image data;

forward projecting the PET image into second SPECT projections;

normalizing the second SPECT projections to generate second normalized SPECT projections;

adding noise to the second normalized SPECT projections to generate second normalized SPECT projections with noise;

reconstructing the second normalized SPECT projections with noise to generate second simulated SPECT image data; and

combining the simulated SPECT image data and the second simulated SPECT image data to create a single set of SPECT image data.

14. The computer-implemented method of claim 11 , further comprising:

obtaining second PET image data acquired after the treatment regimen;

generating second simulated SPECT image data based on the second PET image data and the system and scan parameters; and

comparing the simulated SPECT image data and the second simulated SPECT image.

15. The computer-implemented method of claim 11 , further comprising:

obtaining a dosimetry value of primary tissue of interest or healthy tissue in SPECT image data acquired after the treatment course of the treatment regimen;

identifying the primary tissue of interest and secondary tissue of interest in the PET image data;

determining a value of a secondary-to-primary tissue of interest characteristic;

obtaining a total radiation dose; and

estimating a radiation dose of the secondary tissue of interest based on the dosimetry value, the value of the secondary-to-primary tissue of interest characteristic and the total radiation dose.

16. A computer readable storage medium encoded with computer executable instructions which when executed by a processor cause the processor to:

obtain first PET image data that was acquired prior to a treatment course of a treatment regimen with a SPECT-based treatment/imaging radiopharmaceutical;

obtain system parameters of a SPECT-CT imaging system to be utilized to acquire SPECT image data and scan parameters utilized by the SPECT-CT imaging system to acquire the SPECT image data; and

generate a-simulated SPECT image data by forward projecting the PET image data into SPECT projections based on; the system parameters and the scan parameters and reconstructing the SPECT projections.

17. The computer readable storage medium of claim 16 , wherein the computer executable instructions further cause the processor to:

normalize the SPECT projections to generate normalized SPECT projections;

add noise to the normalized SPECT projections to generate normalized SPECT projections with noise; and

reconstruct the normalized SPECT projections with noise to generate the simulated SPECT image data.

18. The computer readable storage medium of claim 17 , wherein the computer executable instructions further cause the processor to:

extract a second SPECT FOV from the PET image data;

forward project the PET image into second SPECT projections;

normalize the second SPECT projections to generate second normalized SPECT projections;

add noise to the second normalized SPECT projections to generate second normalized SPECT projections with noise;

reconstruct the second normalized SPECT projections with noise to generate second simulated SPECT image data; and

combine the simulated SPECT image data and the second simulated SPECT image data to create a single set of SPECT image data.

19. The computer readable storage medium of claim 16 , wherein the computer executable instructions further cause the processor to:

obtain second PET image data acquired after the treatment regimen;

generate second simulated SPECT image data based on the second PET image data and the system and scan parameters; and

compare the simulated SPECT image data and the second simulated SPECT image.

20. The computer readable storage medium of claim 16 , wherein the computer executable instructions further cause the processor to:

obtain a dosimetry value of primary tissue of interest or healthy tissue in SPECT image data acquired after the treatment course of the treatment regimen;

identify the primary tissue of interest and secondary tissue of interest in the PET image data;

determine a value of a secondary-to-primary tissue of interest characteristic;

obtain a total radiation dose; and

estimate a radiation dose of the secondary tissue of interest based on the dosimetry value, the value of the secondary-to-primary tissue of interest characteristic and the total radiation dose.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 1, 2022
From: SACHS, JONATHAN; CARMI, RAZ
To: GE PRECISION HEALTHCARE LLC
Reel/Frame 061940/0696 →
Continuity (1)
Related Publication 20240185415A1 · Jun 6, 2024
References Cited (9)
US 11238197B1 · Douglas · 2022 [cited by examiner]
US 20090258335A1 · Marmaropoulos · 2009 [cited by examiner]
US 20140072194A1 · Hansis · 2014 [cited by examiner]
US 20140226883A1 · Hong · 2014 [cited by examiner]
US 20240366962A1 · Sjolund · 2024 [cited by examiner]
Barca et al, Expanding Theranostic Radiopharmaceuticals for Tumor Diagnosis and Therapy, Pharmaceuticals, Jan. 2022, pp. 1-20, vol. 15, iss.1, No. 13. DOI: 10.3390/ph15010013. [cited by applicant]
Gains et al., 117 Lu-Dotatate Molecular Radiotherapy for Childhood Neuroblastoma, The Journal of Nuclear Medicine, Jul. 2011, pp. 1041-1047, vol. 52, No. 7. DOI: 10.2967/jnumed.110.085100. [cited by applicant]
Weineisen et al., 68Ga- and 177Lu-Labeled PSMA I&T: Optimization of a PSMA-Targeted Theranostic Concept and First Proof-of-Concept Human Studies, The Journal of Nuclear Medicine, Aug. 2015, pp. 1169-1176, vol. 56, No. 8… [cited by applicant]
Okamoto et al. Radiation dosimetry for 177Lu-PSMA-I&T in metastatic castration-resistant prostate cancer: Absorbed dose in normal organs and tumor lesions, Journal of Nuclear Medicine, 28 sheets, Sep. 22, 2016. DOI:10.2… [cited by applicant]